Blue Star Limited announced its financial results for Q1 FY 2025, reporting a 28.7% growth in consolidated revenue. The company’s Revenue from Operations rose significantly by 28.7% to ₹2,865.37 crore for the quarter ended June 30, 2024, compared to ₹2,226.00 crore during the same period in the previous year. The Operating Profit (EBITDA excluding Other …
Muthoot Capital Services Limited (MCSL), a dynamic Non-Banking Finance Company (NBFC) and a cornerstone of the 137-year-old Muthoot Pappachan Group, is accelerating its commitment to sustainable mobility. The company has secured a significant ₹100 crore debt funding partnership with a UK-based Development Financial Institution (DFI), facilitated by Axis Bank. This investment will fuel MCSL’s electric …
On August 06, 2024, Absolute Sports, a subsidiary of Nazara Technologies and the parent company of Sportskeeda.com, ProFootballNetwork.com, and SoapCentral.com, announced an agreement to purchase the assets of DeltiasGaming.com. DeltiasGaming.com is a leading source of gaming and esports content in the US. The deal, valued at $9,00,000 (~₹7.5 crore), will be paid in one or …
On August 6, 2024, NovaLead’s patented repurposed drug was approved by CDSCO for treating Diabetic Foot Ulcer (DFU) in the Indian market. Ipca Laboratories Ltd will market the drug under the brand name Diulcus. The approval is based on a Phase III study showing that NovaLead’s patented drug, Diulcus®, helps close Diabetic Foot Ulcers (DFUs) …
On August 6, 2024, Tata Elxsi Limited announced a strategic partnership with Skanray, a prominent global MedTech company specialising in diagnostic imaging, critical care, and surgical solutions. This collaboration is set to enhance surgical imaging core technology and software platform development, aiming to revolutionise diagnosis and treatment by incorporating advanced technology modules for greater predictability, …
Aurobindo Pharma Ltd. announced that the US Food and Drug Administration (FDA) has classified its Unit II formulation manufacturing facility, operated by Eugia Pharma Specialities, as ‘Official Action Indicated’ (OAI) following an inspection. The inspection took place from April 25 to May 3, 2024, at the Bhiwadi facility in Alwar, Rajasthan. Implications of OAI Classification …
Symphony Ltd., a leading manufacturer of consumer durables, announced a significant buyback of equity shares along with its June quarter results on Tuesday. The company has approved the repurchase of 2.85 lakh equity shares, constituting 0.41% of its total equity. Each share carries a face value of Rs 2. Share Buyback Details Symphony has set …
On August 6, 2024, AXISCADES Technologies Limited released its financial results for the quarter ended June 30, 2024. For Q1 FY 2025, the company reported a Revenue from Operations of ₹223 crore, reflecting a 4.5% year-on-year (YoY) increase. In U.S. dollar terms, revenue for the quarter stood at $26.9 million, up 2.5% YoY. The company’s …
Morepen Laboratories Limited has successfully concluded its Qualified Institutional Placement (QIP) by raising ₹200 crores. The issue witnessed an overwhelming response, garnering bids worth ₹335 crores, indicating strong investor confidence in the company’s growth prospects. Global Investor Participation The QIP attracted participation from prominent global investors, including Bank of America Securities Europe, Samsung India, Citigroup, …
Gujarat State Fertilizers & Chemicals Limited (GSFC), a Fortune 500 company owned by the Government of Gujarat, has announced its financial results for the first quarter of the fiscal year 2024-25. Despite a 6% increase in revenues from operations, GSFC’s operating profitability was squeezed in Q1 FY24-25 compared to the same period last year. While …
